Anaphylaxis: A 2023 practice parameter update
David B.K. Golden(Johns Hopkins University), Dennis K. Ledford(University of South Florida), Dana Wallace(Nova Southeastern University), Anne K. Ellis(Queen's University), Ronna L. Campbell(Mayo Clinic), Matthew Greenhawt(Asthma and Allergy Foundation of America), Julie Wang(Shanghai Jiao Tong University), Phil Lieberman(University of Tennessee Health Science Center), Susan Waserman(McMaster University), Elissa M. Abrams(Children's Hospital Research Institute of Manitoba), Matthew A. Rank(Mayo Clinic in Arizona), Alyssa G. Burrows(Queen's University), Caroline C. Horner(Washington University in St. Louis), Cem Akin(University of Michigan), Derek K. Chu(Population Health Research Institute), Jonathan A. Bernstein(University of Cincinnati Medical Center), John Oppenheimer(Rutgers, The State University of New Jersey), Marcus Shaker(Dartmouth–Hitchcock Medical Center), David R. Stukus(The Ohio State University), Heather Cruickshank(University of Cambridge), David M. Lang(Cleveland Clinic)
Cited by 282
Related Papers
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
|The Lancet|2020|4.1k
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium
|Journal of Allergy and Clinical Immunology|2006|2.3k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k